Drug
PX 866
PX 866: highest development phase Phase 1/2, developed by United Therapeutics. 3 trial records tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- United Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| PX-866 (SCCHN) NCT01252628 | Phase 1/2 | Incurable Metastatic Colorectal Carcinoma |
| PX-866 NCT01408316 | Phase 1 | Healthy Volunteer |
| PX-866 NCT00726583 | Phase 1 | Advanced Solid Tumors |
Latest
No recent events.
Follow PX 866 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.